Ida Deleskog Lindstrom, Global Medical Affairs Director at Gene Solutions, shared a post on LinkedIn:
“Proud to have participated in American Society of Clinical Oncology (ASCO) Breakthrough in Singapore – a truly global oncology meeting that brought leaders together for meaningful exchange.
The strong scientific program offered rich insights into liquid biopsy, multiomics, and precision oncology. One of the most valuable parts for me was the opportunity to engage with colleagues around our recent work, including the Merit Award poster on SPOT-MAS 10 real-world data from 84,145 individuals (featured by ASCO in its Press Center ahead of ASCOBT26) and our Merit Award-winning oral presentation. It was encouraging to see strong interest in the hybrid tumor-informed and tumor-agnostic ctDNA testing approach described as ‘combining the best of both worlds’.
The Women at ASCO Breakthrough Meet and Greet was another highlight of the event, offering a wonderful chance to reconnect with old friends and meet new ones.
Grateful to Herbert Loong, Annie Wong, Rebecca Dent, Yew Oo Tan, Aaron Tan, Elizabeth Steinberg, Ravindran Kanesvaran, Amit Jain, Omali Pitiyarachchi, Daphne Day, Le Son Tran, Melvin L.K. Chua, Yan Leyfman, Tom Wei-Wu Chen, Eileen Poon, Jennifer Thompson, Brendan Chia Seng Hup, Dang Nguyen and many others for the rich conversations and shared perspectives.
Looking forward to building on these connections and insights as we continue working toward earlier detection and better outcomes for cancer patients.”
Read the full ASCO feature.
Other articles about ASCOBT26 on OncoDaily.
